TELA Stock Analysis: Buy, Sell, or Hold?
TELA - TELA Bio, Inc. Common Stock
$0.65
0.01 (1.19%)
â˛
5d:
+0.62%
30d:
-5.35%
90d:
-26.53%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When TELA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TELA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TELA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TELA is currently trading at $0.65, which is considered slightly low relative to its 30-day fair value range of $0.64 to $0.82.
Technical Outlook: Technically, TELA is showing sideways momentum. Immediate support is located at $0.60, while resistance sits at $0.90.
Market Sentiment: TELA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.10 (+221.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TELA is showing sideways momentum. Immediate support is located at $0.60, while resistance sits at $0.90.
Market Sentiment: TELA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.10 (+221.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.64 -
$0.82
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: Trading 221.1% below Wall St target ($2.10)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.64 -
$0.82
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.90
Current Trend
Sideways
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.25
Wall Street Target
$2.10
(+221.1%)
Revenue Growth (YoY)
-4.5%
Profit Margin
-51.5%
Share & Embed Analysis
Last updated: August 24, 2026 6:42 PM ET
Data refreshes hourly during market hours. Next update: 7:42 PM
Data refreshes hourly during market hours. Next update: 7:42 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 46 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 45 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 54 HOLD |
